ライフサイエンスコーパス: assisted reproductive

1 of imprinted genes in embryos produced using assisted reproductive biotechnologies.

2 rvations in cattle may have implications for assisted reproductive procedures in human beings.

3 ting and genetic counselling before starting assisted reproductive procedures.

4 in predicting successful sperm retrieval and assisted reproductive technique (ART) outcome is unknown

5 roviding data on parenthood rates and use of assisted reproductive techniques (ARTs) after contempora

6 Individuals conceived with assisted reproductive techniques (ARTs) could be at elev

7 The input of fertility specialists and assisted reproductive techniques can further support suc

8 The use of assisted reproductive techniques has also substantially

9 such genetic defects to offspring born from assisted reproductive techniques is increasingly becomin

10 ature on varicocele repair and its effect on assisted reproductive techniques.

11 nce coverage and couples with no interest in assisted reproductive techniques.

12 decreasing multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerc

13 Assisted reproductive technologies (ART) are associated

14 Assisted reproductive technologies (ART) are increasingl

15 Clomiphene and assisted reproductive technologies (ART) are methods use

16 Assisted reproductive technologies (ART) are not yet sys

17 tter that is of utmost concern for improving assisted reproductive technologies (ART) because low-fit

18 Assisted reproductive technologies (ART) can address inf

19 Embryos generated with the use of assisted reproductive technologies (ART) can develop ove

20 Children conceived by assisted reproductive technologies (ART) display a level

21 number of children born since the origin of Assisted Reproductive Technologies (ART) exceeds 5 milli

22 A key factor in the use of assisted reproductive technologies (ART) for diverse spe

23 The use of assisted reproductive technologies (ART) has become incr

24 both intrauterine insemination and in vitro assisted reproductive technologies (ART) procedures perf

25 conservation breeding programs often rely on assisted reproductive technologies (ART) to produce offs

26 Many procedures used in assisted reproductive technologies (ART) to treat human

27 tion (IVF) is one of the most highly pursued assisted reproductive technologies (ART) worldwide.

28 ugh their infertility is often bypassed with assisted reproductive technologies (ART), some accompani

29 Advances in assisted reproductive technologies (ART), specifically s

30 this method holds significant potential for assisted reproductive technologies (ART), where metaboli

31 ons of phthalate metabolites and outcomes of assisted reproductive technologies (ART).

32 15) versus never smokers (N = 44) undergoing assisted reproductive technologies (ART).

33 n (IVF) is the most widely used technique in assisted reproductive technologies (ART).

34 ryo quality provides significant advances in Assisted Reproductive Technologies (ART).

35 Given the relatively low success rates of assisted reproductive technologies (ART; ~25%), additive

36 years of fertility and may begin to turn to assisted reproductive technologies (ARTs) and egg donati

37 nts that include ovulation stimulation, both assisted reproductive technologies (ARTs) and non-ART ov

38 The association between assisted reproductive technologies (ARTs) and the body m

39 Although widely used, assisted reproductive technologies (ARTs) are associated

40 rm cells directly from raw semen samples for assisted reproductive technologies (ARTs) as an alternat

41 Assisted reproductive technologies (ARTs) have been show

42 Assisted reproductive technologies (ARTs) have now contr

43 During the past two decades, assisted reproductive technologies (ARTs) have revolutio

44 The efficiency of assisted reproductive technologies (ARTs) in nonhuman pr

45 The use of assisted reproductive technologies (ARTs) is steadily in

46 inting disorders in children conceived using assisted reproductive technologies (ARTs), and aberrant

47 vel, at high-throughput, would be useful for assisted reproductive technologies (ARTs), as it can all

48 tation development is a gateway to improving assisted reproductive technologies and stem cell researc

49 lications of this observation for the use of assisted reproductive technologies are especially releva

50 enesis, hormonal cycles and the way in which assisted reproductive technologies can be applied, and k

51 edical indications and ethical acceptance of assisted reproductive technologies for adult-onset cance

52 e optimization of semen cryopreservation and assisted reproductive technologies for the critically en

53 known, although recently an association with assisted reproductive technologies has been described.

54 Assisted reproductive technologies in all mammals are cr

55 a novel means to improve the success rate of assisted reproductive technologies in fertility clinics.

56 causes of infertility have been overcome by assisted reproductive technologies such as in vitro fert

57 Assisted reproductive technologies techniques are import

58 ertility is a significant health problem and assisted reproductive technologies to treat infertility.

59 of pregnancies occurred spontaneously, with assisted reproductive technologies used in the remaining

60 al for in vitro gametogenesis to be used for assisted reproductive technologies using NWR iPSCs.

61 iving versus deceased donation, (iii) use of assisted reproductive technologies, (iv) informed consen

62 ts in normal imprinting are found in cancer, assisted reproductive technologies, and several human sy

63 ten million babies conceived globally, using assisted reproductive technologies, fundamental question

64 e differences in risk factors such as use of assisted reproductive technologies, obesity, smoking, an

65 n, and absence of sperm fertilising ability, assisted reproductive technologies, such as in-vitro fer

66 Furthermore, in this era of assisted reproductive technologies, understanding the si

67 man fertility and infertility, and improving assisted reproductive technologies.

68 eing developed to increase the efficiency of assisted reproductive technologies.

69 interactions, with potential applications in assisted reproductive technologies.

70 ese associations were modified by the use of assisted reproductive technologies.

71 his period and could lead to improvements in assisted reproductive technologies.

72 labour induction and caesarean delivery and assisted reproductive technologies.

73 rity, fluidity, and stability to advance the assisted reproductive technologies.

74 le throughout the world are permitted to use assisted reproductive technologies.

75 problem during infertility treatments using assisted reproductive technologies.

76 .7%]; P < .001), and were more likely to use assisted reproductive technology (172 of 692 [24.9%] vs

77 recent observations suggests a link between assisted reproductive technology (ART) and epigenetic er

78 n development has important implications for assisted reproductive technology (ART) and for human emb

79 sing percentage of births are conceived with assisted reproductive technology (ART) and other inferti

80 Whether pregnancies conceived through assisted reproductive technology (ART) are at an increas

81 The methods of gamete manipulation used in assisted reproductive technology (ART) are rapidly proli

82 As assisted reproductive technology (ART) becomes increasin

83 In the past 25 years, the frequency of assisted reproductive technology (ART) births has increa

84 To examine associations of assisted reproductive technology (ART) conception (vs.

85 le partners (median age: 35 y) underwent 437 assisted reproductive technology (ART) cycles for infert

86 e that endogenously elevated estrogen during assisted reproductive technology (ART) exhibits little a

87 ernal age (AMA, >=35 years) women undergoing assisted reproductive technology (ART) face reduced live

88 Use of assisted reproductive technology (ART) has been associat

89 e number of children born through the use of assisted reproductive technology (ART) has been increasi

90 In recent decades, the use of assisted reproductive technology (ART) has increased rap

91 The increasing use of assisted reproductive technology (ART) has raised concer

92 s known about the outcomes of pregnancy with assisted reproductive technology (ART) in women with kid

93 Assisted reproductive technology (ART) involves the mani

94 The use of assisted reproductive technology (ART) is growing, both

95 Assisted reproductive technology (ART) may affect fetal

96 Patients using assisted reproductive technology (ART) may need addition

97 cent data in humans and animals suggest that assisted reproductive technology (ART) might affect the

98 Assisted reproductive technology (ART) refers to process

99 lantation failure (IF) in couples undergoing Assisted Reproductive Technology (ART) treatment.

100 in both natural pregnancies and those after assisted reproductive technology (ART) treatment.

101 Data on live births, assisted reproductive technology (ART) use, and mortalit

102 to investigate 1) whether the association of assisted reproductive technology (ART) with preterm birt

103 ytoplasmic sperm injection (ICSI), a type of assisted reproductive technology (ART), can induce epimu

104 rm injection (ICSI), the most common type of assisted reproductive technology (ART), might damage the

105 In assisted reproductive technology (ART), predictive model

106 tational diabetes, gestational hypertension, assisted reproductive technology (ART), rates of materna

107 men with obesity are also more likely to use assisted reproductive technology (ART), which frequently

108 ir pollution and livebirth among women using assisted reproductive technology (ART).

109 [n = 41 628], and estrogen [n = 16 948]) and assisted reproductive technology (in vitro fertilization

110 d data from the databases of the Society for Assisted Reproductive Technology (SART) in the US and th

111 These findings, captured by Society for Assisted Reproductive Technology (SART) national data, u

112 registry-based model produced by Society for Assisted Reproductive Technology (SART).

113 Infants conceived with assisted reproductive technology accounted for 0.6 perce

114 The use of assisted reproductive technology accounts for a dispropo

115 ected prevalence of monozygotic twinning, of assisted reproductive technology among parents, and of d

116 0, to August 23, 2021, using the Society for Assisted Reproductive Technology and BabyCenter, an onli

117 o evaluate whether pregnancies conceived via assisted reproductive technology and exposed to Hurrican

118 authors conducted a validation study of the assisted reproductive technology and infertility drug us

119 ere born in 1996 and 1997 and conceived with assisted reproductive technology and used as a compariso

120 Pregnancies resulting from assisted reproductive technology are associated with an

121 embryo transfers reported to the Society for Assisted Reproductive Technology between 2014 and 2016.

122 d reproductive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reportin

123 oocytes at member clinics of the Society for Assisted Reproductive Technology Clinic Outcomes Report

124 data from member clinics of the Society for Assisted Reproductive Technology Clinical Outcomes Repor

125 S region, state FP mandate status, number of assisted reproductive technology cycles performed, and n

126 older, low oocyte yield, and 2 or more prior assisted reproductive technology cycles; reproductive ou

127 national data collected from the Society for Assisted Reproductive Technology for 33 863 recipients u

128 of gestation or later, those conceived with assisted reproductive technology had a risk of low birth

129 low birth weight associated with the use of assisted reproductive technology has been attributed lar

130 of the few species, beside humans, in which assisted reproductive technology has important clinical

131 Live-birth rates after treatment with assisted reproductive technology have traditionally been

132 We linked a census of treatment with assisted reproductive technology in South Australia to a

133 We linked data from cycles of assisted reproductive technology in the Society for Assi

134 ss other states and to understand why use of assisted reproductive technology is not a risk factor fo

135 singleton infants conceived with the use of assisted reproductive technology may also have a higher

136 e otherwise infertile men conceived using an assisted reproductive technology needs further evaluatio

137 mproved semen parameters, DNA integrity, and assisted reproductive technology outcomes after varicoce

138 tibodies are associated with infertility and assisted reproductive technology outcomes is unclear; al

139 We analyzed data on outcomes of assisted reproductive technology procedures as reported

140 We analyzed national data on assisted reproductive technology reported to the Centers

141 and ICSI cycles reported to the US National Assisted Reproductive Technology Surveillance System dur

142 We also profiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptio

143 he rate of low birth weight after the use of assisted reproductive technology to the rate in the gene

144 Four physicians from two assisted reproductive technology treatment centers in th

145 Assisted reproductive technology use does not appear to

146 Assisted reproductive technology use was previously vali

147 care, multiple pregnancy, placenta praevia, assisted reproductive technology use, macrosomia with a

148 vitro fertilization (IVF) is the most common assisted reproductive technology used to treat infertili

149 s data to evaluate trends in infertility and assisted reproductive technology utilization rates, incl

150 Assisted reproductive technology was associated with a l

151 The use of assisted reproductive technology was associated with an

152 Use of assisted reproductive technology was associated with dec

153 Assisted reproductive technology was associated with inc

154 Use of assisted reproductive technology was compared between ma

155 atural fecundity can be achieved by means of assisted reproductive technology when there are favorabl

156 igher levels of CCNA2 in patients undergoing assisted reproductive technology who had successful preg

157 es are more common among children born after assisted reproductive technology with fresh embryo trans

158 eight (<1500 g) among infants conceived with assisted reproductive technology with the rates in the g

159 maternal age, BMI, gravidity, parity, use of assisted reproductive technology, adverse obstetric hist

160 rine surgery, induction of pregnancy through assisted reproductive technology, and any concurrently o

161 on delayed childbearing, infertility, use of assisted reproductive technology, and career alterations

162 record of infertility but no treatment with assisted reproductive technology, and pregnancies in wom

163 ty treatment (ie, intrauterine insemination, assisted reproductive technology, fertility preservation

164 d infertility, secondary infertility despite assisted reproductive technology, negative self-image, a

165 ncluding the safety of contraception, use of assisted reproductive technology, preservation of fertil

166 PGT-M for monogenic PKD, like other forms of assisted reproductive technology, raises important ethic

167 nancies in women who received treatment with assisted reproductive technology, spontaneous pregnancie

168 antation remains a significant challenge for assisted reproductive technology, with implantation fail

169 infertility causes, childbearing decisions, assisted reproductive technology, workplace support, and

170 ly validated by linkage with the Society for Assisted Reproductive Technology-Clinical Outcome Report

171 ul genetic counseling of couples who opt for assisted reproductive technology.

172 en a growing focus on spermatozoa sorting in assisted reproductive technology.

173 matured in vitro to produce spermatozoa for assisted reproductive technology.

174 ryo vitrification is a standard procedure in assisted reproductive technology.

175 ility as time to pregnancy >=12 mo or use of assisted reproductive technology.

176 rance coverage of fertility preservation and assisted reproductive technology.

177 rance coverage of fertility preservation and assisted reproductive technology.

178 maintenance of anisogamy and for outcomes of assisted reproductive technology.

179 e potential or decrease the need for complex assisted reproductive technology.

180 physiology may affect the outcomes of modern assisted reproductive technology.

181 ultiple gestations resulting from the use of assisted reproductive technology.

182 ce patterns and in outcomes after the use of assisted reproductive technology.

183 g pregnancy of more than 12 months or use of assisted reproductive technology; and miscarriage, defin

184 g pregnancy of more than 12 months or use of assisted reproductive technology; and miscarriage, defin

185 Assisted reproductive therapies (ART) have become increa

186 ped countries at least 1% of births are from assisted reproductive therapies (ART).

187 PTRX3 are reflective of treatment outcome in assisted reproductive therapy (ART) couples treated by i

188 males, offering new possibilities to improve assisted reproductive therapy in women with compromised

189 or the benefit of human reproductive health, assisted reproductive therapy, and contraception, as wel

190 cific diagnostic evaluation before receiving assisted reproductive treatment.

191 Boston, Massachusetts, clinics who underwent assisted reproductive treatments between 1994 and 2003,